S. 3630 · 116th Congress
Facilitating Innovation to Fight Coronavirus Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
SasseSponsorNo cosponsors.
This bill provides immunity from civil liability to health care providers for certain actions taken during the COVID-19 (i.e., coronavirus disease 2019) public health emergency and lengthens the terms of certain medical patents related to the treatment of COVID-19.
What it does: CRS summary · Introduced in Senate · May 6, 2020
Facilitating Innovation to Fight Coronavirus Act
This bill provides immunity from civil liability to health care providers for certain actions taken during the COVID-19 (i.e., coronavirus disease 2019) public health emergency and lengthens the terms of certain medical patents related to the treatment of COVID-19.
Specifically, when testing for or treating COVID-19 during the public health emergency, a health care provider may not be held liable in any federal, state, or local civil proceeding for (1) using or modifying a medical device for an unapproved use or indication; (2) practicing without a license or outside of an area of specialty, if instructed to do so by an individual with such a license or within such an area of speciality; or (3) conducting the testing of, or providing treatment to, a patient outside of the premises of standard health care facilities.
Additionally, certain medical patents that are issued with respect to the treatment of COVID-19 are deemed not to begin until the termination of the presidential emergency declaration relating to COVID-19 and are extended for an additional 10 years.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Facilitating Innovation to Fight Coronavirus Act
Latest action (May 6, 2020): Read twice and referred to the Committee on the Judiciary.
Policy area: Law · Origin: Senate · Introduced: May 6, 2020
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.